Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "United States Home Healthcare Market Report by Component, Indication, States and Company Analysis, 2025-2033" report has been added to ResearchAndMarkets.com's offering.
The United States Home Healthcare Market is expected to see substantial growth, rising from US$ 115.13 Billion in 2024 to US$ 210.25 Billion in 2033. This growth reflects a strong Compound Annual Growth Rate (CAGR) of 6.92% from 2025 to 2033.
The drivers of this growth are an aging population, a higher incidence of chronic diseases, and a preference for in-home care services, which promote patient comfort and convenience. 
Home healthcare has gained immense popularity in recent years in the United States for a number of reasons. The boom generation that is aging is now looking for alternatives to hospitalization and wants the convenience of recovery and management of chronic diseases in the comfort of home. Further, technology has allowed medical professionals to provide effective and efficient care from a distance, making the service more accessible.
Insurance providers have also come to appreciate the worth of home healthcare, tending to cover a wider array of services, further increasing its popularity. Therefore, home healthcare is becoming an essential part of the American healthcare system, providing affordable solutions prioritizing patient convenience and health.
Growth Drivers in the United States Home Healthcare Market
Aging Population and Increasing Chronic Diseases
The United States has a rapidly growing population of the elderly, with millions of people aged above 65 needing constant medical care. This age pattern is among the most powerful forces behind the home healthcare market. Older people tend to have chronic conditions like cardiovascular disease, diabetes, arthritis, and respiratory ailments, which need long-term treatment and observation.
Home healthcare is a cost-effective, comfortable, and personalized option compared to hospitalization or long-term care institutions. The number of Americans aged 65 and older will grow from 58 million in 2022 to 82 million in 2050 (a 47% increase), and the 65-and-older segment's proportion of the entire population is expected to increase from 17% to 23%.
Cost-Effectiveness Compared to Institutional Care
The increasing hospital and nursing facility costs are driving patients and healthcare systems alike to look toward home healthcare as a viable option. Home healthcare services, including skilled nursing, physio, wound care, and chronic disease management, can be provided at a fifth of the price of inpatient care.
This is especially significant in the U.S., where healthcare costs are among the highest in the world. Home healthcare usage is promoted by insurance companies and government programs more and more to eliminate the cost burden on the healthcare system. For patients, home-based care eliminates costs of prolonged hospitalization, transportation, and ancillary services.
Technological Advances in Remote Care
Advancements in healthcare technology have revolutionized the business of home healthcare in the United States. The convergence of telehealth platforms, wearable monitoring devices, mobile applications, and artificial intelligence-enabled diagnostic solutions enables healthcare professionals to provide quality care remotely. Patients with conditions such as heart failure, diabetes, or COPD can now be continuously monitored in real time without multiple hospital visits. All this enhances drug compliance, increases patient safety, and prevents hospital readmissions.
Technology also facilitates caregivers to identify early warning signs and act in a timely manner, enhancing patient outcomes. U.S. Food and Drug Administration is issuing the launch of a new initiative, Home as a Health Care Hub, to assist in reimagining the home setting as a central part of the health care system, with the aim of driving forward health and wellness for everyone in the U.S. Although most care options are presently trying to utilize the home as a virtual clinical location, few have contemplated the structural and critical aspects of the home that will be needed to accommodate this transference of care.
Challenges in the United States Home Healthcare Market
Workforce Shortages and Training Gaps
One of the biggest challenges the U.S. home healthcare market confronts is the lack of capable health-care practitioners. With demand increasing fast for home care, great pressure is placed on the workforce, such as nurses, therapists, and home health aides. Numerous professionals are being overloaded, and as a result, burnout and high turnover occur.
Also, training deficits are present, especially in managing sophisticated technologies and multiple complex chronic conditions in the home environment. The absence of standardized training and certification programs makes service quality even more difficult. For patients, this workforce stress can lead to variable delivery of care and extended wait times for services. The solution to this entails investment in workforce development, improved wages, and career advancement opportunities to recruit and retain the best talent.
Regulatory and Reimbursement Complexities
The U.S. home healthcare market is confronted by complicated regulatory environments and reimbursement issues that interfere with seamless market expansion. Home care services are regulated by strict state and federal regulations, making differences in compliance needs across states. Administrative tasks of licensing, quality reporting, and documentation frequently burden providers.
Reimbursement concerns bring an added layer of complexity, as Medicare, Medicaid, and private insurance coverage differ markedly. Certain vital services and sophisticated technologies are poorly reimbursed, making them unaffordable and inaccessible for patients. Smaller providers especially face financial unsustainability under such circumstances. Reimbursement delays also impact cash flow, which poses operational challenges.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value (USD) in 2024 | $115.13 Billion |
| Forecasted Market Value (USD) by 2033 | $210.25 Billion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | United States |
Company Analysis: Overviews, Key Persons, Recent Developments, SWOT Analysis, Revenue Analysis
- 3M Healthcare
- Apple Inc.
- Arkray, Inc.
- B. Braun Melsungen AG
- Becton, Dickinson And Company
- F. Hoffmann-La Roche AG
- Fresenius SE & Co KGaA
- Hollister Inc.
Market Segmentations
Component
- Services
- Equipment
Indication
- Neurological & Mental Disorders
- Diabetes & Kidney Disorders
- Cancer
- Respiratory Disease & COPD
- Mobility Disorders
- Cardiovascular Disorder & Hypertension
- Wound Care
- Maternal Disorders
- Others
Top States
- California
- Texas
- New York
- Florida
- Illinois
- Pennsylvania
- Ohio
- Georgia
- New Jersey
- Washington
- North Carolina
- Massachusetts
- Virginia
- Michigan
- Maryland
- Colorado
- Tennessee
- Indiana
- Arizona
- Minnesota
- Wisconsin
- Missouri
- Connecticut
- South Carolina
- Oregon
- Louisiana
- Alabama
- Kentucky
- Rest of United States
For more information about this report visit https://www.researchandmarkets.com/r/orygmb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
